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Family communication about genetic information enables informed medical and reproductive 
decision-making. The literature suggests a significant proportion of genetically at-risk family 
members remain uninformed about genetic risk information as a result of non-disclosure. 
This study explored the experiences of New Zealand families communicating about a 
diagnosis of type 1 myotonic dystrophy (DM1). Eligible individuals were identified and 
recruited from the New Zealand (NZ) MD Prev study, a nationwide study which aimed to 
determine the prevalence, impact and costs of genetic muscle disorders across the lifespan. 
Twelve qualitative semi-structured interviews were conducted with 17 participants. The 
findings demonstrate diversity among and within families, with several distinct family 
narratives described. Most participants reported a motivation to tell relatives about their 
diagnosis to promote autonomy. Women were pivotal throughout communication processes 
and this was often tied to the concept of maternal responsibility and a desire to promote 
relatives’ reproductive autonomy.  The diagnosis of DM1 and the subsequent family 
communication decisions altered relationships for many, with both positive and negative 
impacts described.  The findings demonstrate that individuals require time to explore the 
impact of a diagnosis of DM1 on self, family and intimate partner relationships to anticipate 
unique communication challenges. Genetic counsellors can use these findings to inform their 
approach to counselling families with DM1. Longitudinal genetic counselling may be 
beneficial as a way to provide individuals with life stage specific support as they 
communicate with their relatives about a diagnosis of DM1.  
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Genetic information is family information (Forrest et al., 2003; Gaff et al., 2007). When an 
individual is diagnosed with a genetic condition, genetic testing is often available to ‘at-risk’ 
relatives, to clarify their genetic status. Knowledge of a genetic condition may provide family 
members with a choice about whether or not they access genetic testing.  The justification for 
family communication can be condition dependent. Justification for family communication 
may be based around availability of treatment or prevention of symptoms/disease in an 
individual with the condition, severity of disease, and age of onset.  For a condition like 
myotonic dystrophy, knowledge allows for targeted symptom management (Laurent et al., 
2011, Takeshima et al., 2018) and promotes reproductive choice.   
Type 1 myotonic dystrophy (DM1) is a progressive and degenerative condition (Machuca- 
Tzili, Brook & Hilton-Jones, 2005), most commonly associated with myotonia, progressive 
muscle weakness, and other multi-systemic implications affecting the brain, eyes, heart and 
endocrine system (Machuca-Tzili et al., 2005; Pavicevic et al., 2013). This condition is 
caused by a triplet repeat expansion of the base sequence ‘CTG’ in the DMPK gene, which is 
inherited in an autosomal dominant manner. The expansion is unstable between generations, 
particularly with maternal inheritance (Harley et al., 1993), resulting in generational 
anticipation. The normal range of ‘CTG’ repeats in individuals is 5-35 (Kamsteeg et al., 
2012). Individuals with 38-49 repeats are considered to be pre-mutation carriers (Kamsteeg et 
al., 2012). Premutation carriers do not have a clinical phenotype, but they are at-risk of 
having a child with DM1, as repeat sizes within this range are vulnerable to expansion 
(Kamsteeg et al., 2012). 
A correlation can be observed between the length of the repeat and the disease severity, 
meaning that DM1 generally is more severe and has an earlier age of onset with each 
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successive generation (Machuca-Tzili et al., 2005). Age of onset can range from birth to later 
in adulthood, with variable clinical presentation. Individuals with DM1 can range from being 
mildly affected adults who may have cataracts or mild myotonia; to adults with a classical 
form which may include myotonia, muscle weakness, cardiac problems and diabetes; and 
newborns with a potentially life limiting congenital form resulting in hypotonia, breathing 
difficulties, and cognitive impairment. Women affected with DM1 are also more likely to 
develop polyhydramnios and a worsening of symptoms during pregnancy, specifically 
myotonia (Awater, Zerres & Rudnik-Schoneborn, 2012; Johnson et al, 2015).  Family 
communication is important in the context of DM1 as a number of the medical implications 
of DM1 can be effectively managed with knowledge and medical intervention, improving 
quality of life and reducing mortality (Laurent et al., 2011, Takeshima et al, 2018, Ashizawa 
et al., 2018). For example, individuals with myotonic dystrophy can have life threatening 
reactions to anesthetics and therefore careful monitoring and management is required when 
considering surgeries and general aesthetic use (Ashizawa et al., 2018).  Individuals with 
DM1 are also susceptible to diabetes, and knowledge of the condition means individuals can 
undergo formal glucose tolerance testing, and can access treatment and implement lifestyle 
changes in a timely manner (Ashizawa et al., 2018). Knowledge of a genetic diagnosis in the 
family also enables individuals to make informed reproductive decisions, and may allow 
individuals to access government funded reproductive technologies in New Zealand, 
including preimplantation genetic diagnosis (PGD).  
Various factors have been identified as having an impact on the tension that exists 
surrounding disclosure of genetic risk information within family units. While it is thought 
that non-disclosure is more frequently a passive outcome rather than an intentional act (Gaff, 
Collins, Symes & Halliday, 2005), it is clear that most individuals at genetic risk do not 
receive sufficient information from their family members to be able to make an informed 
 5 
decision about accessing genetic testing (Menko et al., 2013).  ‘Closeness’ of family 
relationships can both assist and hinder the process of communication (Forrest et al., 2003; 
McGinvern et al., 2004; Wilson et al., 2004). For individuals who withhold genetic risk 
information from their relatives, the most commonly reported explanation is not knowing a 
relative personally (d’Agincourt-Canning, 2001; Wilson et al., 2004; Mesters et al., 2005; 
Landsbergen et al., 2005).  Disconnection and loss of contact resulting from divorce, 
separation and adoption have also been reported to impede family communication processes 
(Forrest et al., 2003; Healy et al., 2017). Personal views and feelings about communication 
and the utility of genetic testing can act to motivate or inhibit disclosure (Hamilton, Bowers 
& Williams, 2005; d’Agincourt-Canning, 2001).  Furthermore, emotional barriers have been 
described as restricting communication about genetic information (Forrest et al., 2003). 
Conversely, there are a number of factors which have been reported to promote family 
communication. The literature describes the important role that ‘messengers’ play in family 
communication. ‘Messengers’ are key individuals in families who take lead roles in 
disseminating genetic information in the family (Keenan et al., 2005; Wilson et al., 2004). 
Importantly, messengers may be unaffected relatives or partners (Wiens et al., 2013). 
Additionally, several studies have demonstrated a gender effect on disclosure of and 
communication about genetic information (d’Agincourt-Canning, 2001; Gaff et al., 2005; 
Hallowell et al., 2005; Finlay et al., 2008; Bruwer et al., 2013), whereby women are 
dominant in communication processes and are generally considered to be the ‘gate-keepers’ 
of genetic information (Keenan et al., 2006).  
Genetic counselling plays an integral role in the delivery of best practice genetic healthcare. 
The Human Genetics Society of Australasia states that genetic counsellors have a role in 
offering clients “support and assistance in conveying genetic information to ‘at-risk’ 
relatives” (HGSA, 2008, p.6). Family systems theory suggests genetic health professionals 
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should “encourage individuals, partners and their family members to anticipate the impact 
genetic information may have, specifically on ways of communicating and relating to each 
other” (Galvin & Young, 2010, p.115). However, genetic health professionals generally do 
not contact an individual’s relatives directly to inform them of their genetic risk, due to the 
practical, ethical and legal requirements to respect patient confidentiality and to support 
individual autonomy (Lee, 2013). New Zealand and international guidelines allow health 
professionals to disclose genetic information only in such circumstances whereby potential 
harm to the relative that could arise through non-disclosure is considered to be serious (Lee, 
2013; Menko et al., 2013). While genetic health professionals can feel uneasy about the 
possibility of family members remaining unaware of their genetic risk, and often describe 
feeling a sense of responsibility towards clients’ families (Bower et al., 2002; Dugan et al., 
2003; Dheensa, Fenwick, Shkedi-Rafid, Crawford & Lucassen, 2016), there are conflicting 
opinions in the literature as to whether and to what extent genetic services are responsible for 
notifying individuals of their genetic risk (Lehmann, Weeks, Biener & Garber, 2000; 
Andorno, 2004; Suthers et al., 2006).  
A number of intervention studies have demonstrated that genetic health professionals can 
have an impactful role in the notification of at-risk family members. The South Australian 
Clinical Genetic Service developed an intervention whereby genetic health professionals 
directly notified relatives at-risk of hereditary cancer conditions, by letter, without 
compromising the privacy of the proband (Suthers et al., 2006). After two years, the 
proportion of relatives per family who underwent predictive testing was 40% in the 
intervention group, as opposed to 23% in families who received standard care (Suthers et al., 
2006). More recently, a telephone genetic counselling intervention was assessed in a 
randomised controlled trial (Hodgson et al., 2016). While no statistically significant 
difference was observed between the intervention cohort and the cohort who received 
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standard care, more frequent contact of relatives with the genetics service was found in the 
intervention cohort in families where the genetic condition was associated with a higher risk 
to offspring (Hodgson et al., 2016). 
While there is a significant amount of literature exploring the tension surrounding family 
communication about genetic information, these studies report conclusions from a limited 
number of genetic conditions and demographic contexts, with no studies exploring family 
communication in the setting of a diagnosis of myotonic dystrophy. Exploration of 
communication in families with DM1 provides insight into the ways in which individuals 
approach communication regarding an inherited muscular degenerative condition which has a 
range of symptoms, some of which can be managed with early diagnosis and treatment, 
thereby offering improved outcomes. Furthermore, no studies have been conducted exploring 
family communication within New Zealand; therefore this study contributes to the 
international perspective on family communication which is important in an increasingly 
global world. The aim of this study was to explore the experiences of New Zealand families 
communicating about a diagnosis of type 1 myotonic dystrophy. 
Methods 
A qualitative approach was taken to examine experiences of family communication for 
individuals with DM1. Ethics approval for the present study was granted by the Department 
of Health Sciences Human Ethics Sub-Committee at the University of Melbourne (HESC 
reference number 1748593). 
Setting 
This study is a sub-study of a New Zealand-wide prevalence and impact study of genetic 
muscle disorders, MD Prev (Theadom et al., 2016). MD Prev aimed to determine the number 
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of individuals diagnosed with a genetic muscle disorder living in New Zealand on the point 
prevalence date of 1st April 2015. MD Prev collected histological and genetic verification of a 
diagnosis, as well as other medical and demographic information. Ethics approval for MD 
Prev was granted by the New Zealand Northern Health & Disability Ethics Committee 
(14/NTB/118). 
Sampling  
Purposive sampling was utilised to deliberately select participants with particular 
characteristics to enhance sample coverage. Demographic data held by the MD Prev study 
was utilised to select for: participants across different regions of New Zealand, gender 
balance, a mix of individuals who either had or had not been seen by a genetics service, and 
individuals of Māori descent.  
Recruitment  
Participants were recruited from the MD Prev study. Inclusion criteria were that participants 
had received a diagnosis of type 1 myotonic dystrophy for themselves or for a child; had 
provided consent to being recontacted about future research opportunities; had the capacity to 
provide consent; were over the age of 18; and were able to participate in an English language 
interview. Some participants requested that a partner or unaffected parent also be present for 
the interview. Partners and parents provided consent to participate. Some individuals with 
DM1 had difficulty with speech, and therefore family members helped to communicate their 
experiences. For others, parents were central to communication processes and therefore 
individuals felt they should be present for the interview to capture the family’s experience 
communicating the diagnosis of DM1. This was participant driven.  
Thirteen participants were contacted by telephone or via email by an MD Prev researcher, 
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MR, extending an invitation to take part. Twelve individuals who agreed to participate were 
contacted by ST and were emailed a participant information sheet, a consent form, and a 
suitable time and location for the interview were confirmed. Interviews were conducted 
between 03/17 and 08/17. 
Procedures 
Participant interviews focused on individuals’ experiences of receiving a diagnosis of DM1 
for themselves or for their child, and experiences with family communication following their 
diagnosis. The development of the interview guide was informed by evidence identified in 
the literature surrounding family communication about genetic conditions, and by the clinical 
experience of the research team. Interviews were audio recorded and transcribed verbatim. 
Transcripts were de-identified with pseudonyms used to protect the confidentiality of 
participants and their families. Transcripts were imported into NVivo 11 (QSR International 
Pty Ltd., Melbourne, Australia) for storage and management.  
Data Analysis 
Thematic analysis was utilised to identify and extract themes directly from participant 
responses (Braun & Clarke, 2013). The lead researcher read and critically analysed each 
transcript multiple times, searching for important ideas and documenting emergent themes. A 
coding scheme was then developed to capture important ideas emerging from the data and 
these were organised into categories from which themes were extracted. Theme development 
was an ongoing collaborative and reflexive process. Themes were compared across 
transcripts and in relation to characteristics purposively sampled for. Themes were then 
collaboratively discussed with ST, AM and SW and organised into concepts. Four transcripts 
were randomly selected and independently analysed by AM to cross check coding and 
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interpretation of data. Transcripts were continually re-read and analysed for comparison as 
the coding system evolved with the emergence of new ideas in later transcripts.  
 
Results 
We interviewed 13 individuals with DM1, two unaffected parents, and two spouses. Table 1 
summarises the participant demographics. Approximately 15% of the NZ population identify 
as being Māori, which is similar to our cohort (11%). ‘Pākehā’ is a term used to describe 
New Zealanders of Caucasian descent.  
 
Participants 
Twelve interviews were conducted. Eleven were conducted in person and one interview was 
conducted by telephone. Interview length varied from 60-140 minutes. Three participants had 
other family members present for the interview who provided consent to take part in this 
research, resulting in a total of 17 participants. In addition to the 12 individuals with DM1, 
two unaffected parents, two spouses and one son with DM1 over the age of 18 consented to 
participate.  
Table I. Participant Demographics 
 
In presenting the findings, verbatim quotes have been used as exemplars of the themes that 
emerged from thematic analysis. Pseudonyms have been used throughout participant quotes 
to protect the confidentiality of participants and their families. Although a number of themes 
were captured through this research, six key themes are presented below.  
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The results presented were consistent across the demographic characteristics that were 
purposively sampled for, including ethnicity, region, and whether participants received a 
molecular diagnosis or a clinical diagnosis. 
 
Figure I. Summary of Themes 
 
Diversity in Family Communication 
Participant narratives revealed the diversity in the way families approached communication 
about DM1. Some participants described that DM1 was talked about openly.  
“Everyone knows about it, everyone talks about it… It’s not under the carpet, it’s all out in 
the open. So there’s never been a time where I had to go and say ‘oh I’ve got muscular 
dystrophy’.”                                                                            Participant 1, female with DM1                                                                                                                                                                     
                                      
Others described that conversations about DM1 were actively avoided within their family.  
“It’s like an unspoken thing. It’s there, we don’t talk about it though.”           
                                                                                              Participant 11, male with DM1               
                                                                                                                                                    
  
To Tell or Not to Tell? 
The majority of participants reported that either they or a relative disclosed their diagnosis of 
myotonic dystrophy to immediate family members and to family members with whom they 
had close relationships. Although most individuals reported immediate family members were 
informed about the diagnosis, individuals described the emotional difficulties associated with 
being the ‘messenger’. For example, one woman described the difficult task of informing her 
three sons following her husband’s diagnosis of myotonic dystrophy. 
“I knew that with that phone call it was going to change their lives (crying)...It was a hard 
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one to make but I tried not to let them hear that in my voice. And ah of course there was the 
chance that they could have missed and they didn’t have [DM1] so I was trying to, when I 
spoke to them I tried to promote that.”                                Participant 9, spouse and mother  
A number of participants actively stepped past a ‘gate-keeper’ to ensure at-risk relatives were 
informed. 
“My uncle Cam as I said, refusing point blank to discuss it at all. And his two kids who are 
old enough to start showing symptoms now, I sat them down last Christmas and talked to 
them about it, because he wouldn’t. I said ‘they have to know’.”                                     
                                                                                                Participant 4, female with DM1                
Some participants described ‘not telling’ at least one immediate family member, or being on 
the receiving end of non-disclosure. Disconnection, stemming from estrangement, conflict, 
adoption and geographical distance were described as the key barriers to disclosure. For 
example, one woman described how disconnection stemming from an adoption that took 
place in her family introduced a barrier to communication. 
“We don’t want to be selfish and break up you know a happy family. So we just decided that 
we won’t contact or get in contact with that side of the family.”                                          
                                                                                                Participant 6, female with DM1  
Although most participants stated that immediate family members were actively told about 
their diagnosis of myotonic dystrophy, most participants assumed that information about their 
diagnosis had been communicated to extended family members. 
“I don’t think there’s much point in bringing it up with [the extended family], uhm, unless 
they have it as well. It’s more of a, they all know, uhm, well I’m pretty sure that they do.”      
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                                                                                                 Participant 11, male with DM1 
The Role of Women in Communication  
The majority of participants described a key woman who was responsible for communication 
about genetic risk information within the family. Most female participants identified 
themselves or another female relative as this person.  
“After we got Lucy’s (daughter) diagnosis I thought, ‘I’m going to tell all the cousins 
because that’s what [the genetic service] is telling me to do.’”     
                            Participant 3, female with DM1 & mother of a child with congenital DM1       
Conversely, the majority of males did not disclose their diagnosis of myotonic dystrophy to 
at-risk relatives. Rather, wives, mothers and sisters were described as taking on this role in 
families. 
“I told Lily (brother-in-law’s wife) with a phone call so that she could tell Arnold (brother-
in-law). And, uhm, I, uhm, I told Daisy (brother-in-law’s wife) so that she would tell Brian 
(brother-in-law) and they told James (brother-in-law) so- and of course I told my own 
family.”  
                                                                                      Participant 9, spouse and mother 
When describing ongoing communication about myotonic dystrophy, male participants 
described feeling more comfortable talking with female relatives in comparison to male 
relatives.  
“My mum would be my first person I would go to...It’s just we (father with DM1 and son) 
don’t talk about it. I don’t think it is with me, but I think it is with older men, they’re very ‘I’ll 
be fine’.”                                                                                    Participant 11, male with DM1                        
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Male participants also identified their female relatives as being responsible for engaging them 
with genetic health and prompting them to consider genetic testing. One participant described 
how his sister became aware of DM1 and subsequently alerted him to it, after she had 
gathered family history information for family planning purposes. 
 “She (sister) had done a lot of genealogy work on the family so she was more aware of, not 
the symptoms but the prevalence of it in my father’s family. So whereas, I wasn’t at all. I 
knew I had an uncle who was unwell, you know, who had it, and a cousin who had it but I 
thought, you know, I’m not in a wheelchair...If she hadn’t prompted me to get tested I 
probably wouldn’t have got tested until something like maybe the cataracts.”        
                                                                                                    Participant 16, male with DM1 
Furthermore, some male participants described encountering barriers to accessing genetic 
testing, despite being told about the presence of myotonic dystrophy in the family. 
“She’d (sister) told me to go and get tested but never told me the right name so that I could 
go to my doctor... I said [to my doctor] ‘you know this’ and he said ‘there’s no such thing’. 
So I never had the correct name so I never got tested for it.”              
                                                                                              Participant 12, male with DM1                                                                          
Promoting Autonomy  
Many participants described the concept of autonomy when considering whether to share 
information about a diagnosis of myotonic dystrophy. Many participants described feeling 
motivated to inform family members so that their relatives could make informed reproductive 
decisions.  
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“His (brother’s) daughter is 17… She knows that Lucy has [DM1], so I hope that and, ah, 
she’s not, she’s very innocent you know. But I just hope that she’s armed with the information 
to go and get tested down the line in ten years’ time if she meets someone and wants to have 
kids, you know.”                            
                               Participant 3, female with DM1 & mother of a child with congenital DM1                                                               
One participant expands on the concept of reproductive autonomy motivating 
communication, linking this to the possibility of anticipation, and therefore congenital 
myotonic dystrophy. 
“With the girls (cousins), if they had children, uhm, and they had it and didn’t know it, their 
children could end up with, uhm, not only a worse but you can also get a congenital form, 
which causes brain retardation and developmental problems and all of that sort of thing. And 
often that’s how families find out.”                                 Participant 4, female with DM1 
 
The majority of participants described that they felt it was important to inform relatives about 
DM1 so that their family members could make informed medical decisions. 
“I think it’s really a duty to let people know, because they could also have the condition 
unbeknown and something could happen to them and they’ll need medical attention. And 
maybe without the knowledge that there is this condition, uhm, it would be more difficult to 
treat and maybe not successful.”                                                                                          
                                                                                                   Participant 8, male with DM1            
                                                                                                                                                   
Two participants who had been on the receiving end of non-disclosure described feeling like 
control had been taken away from them by not being informed about the condition before 
making reproductive decisions. Both of these women had a child with myotonic dystrophy 
(one having a child with the congenital form) and both learnt after their pregnancies that 
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myotonic dystrophy had been identified and known about in their families for some time 
prior. These women expressed decisional regret, describing how they would have made 
different reproductive decisions, had they known about myotonic dystrophy. 
“I definitely wouldn’t have tried to get pregnant naturally. I got married and then 2007 we 
were only 2 or 3 months and then I got pregnant and you just think everything is you know, is 
just going to all go like everything else went you know before. But, I feel like some of that 
control was taken away by the, that family, not telling us.”                                                    
                             Participant 3, female with DM1 & mother of a child with congenital DM1                                                               
 
“1: So she (paternal grandmother) told mum that there was nothing… 
2: Which is a shame really because we could have…   
1: You could have avoided having me? 
2: Hey? 
1: You could have avoided having me? 
2: Yeh, well, yeh (silence).”                      
                                                        Participant 1, female with DM1 & Participant 2, mother 
 
Feeling like communication decisions altered family relationships 
Some participants described that relationships had been impacted by decisions to disclose or 
withhold information about myotonic dystrophy within the family. Some participants 
explained that disclosure negatively impacted particular family relationships. 
“I don’t think he (brother) likes seeing me anymore (crying) because I remind him. So he’s 
more, he doesn’t visit as often as he used to. Uhm, he doesn’t want to be reminded, and it’s 
possible that he or his children have it… I think that, ah, when he thinks of me, he thinks of 
DM1 and he really doesn’t want to be reminded that it’s in the family.”                           
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                                                                                                Participant 12, male with DM1 
                                                                                                                                                                                      
Others described feeling like disclosure strengthened relationships with particular family 
members. 
“I think I had a good relationship with my mother and it’s probably strengthened my one 
with my sister.”                                                                        Participant 16, male with DM1                                                                                                                                                       
                                                                                                                                                        
Only negative implications were described as a result of non-disclosure.  
“I’ve never spoken to them since.”          
                              Participant 3, female with DM1 & mother of a child with congenital DM1                                                                       
 
Some participants described that decisions to inform a partner about DM1 resulted in a strain 
or breakdown of an intimate partner relationship.  
“People have a change of heart. My partner said he doesn’t know if he could look after me 
after [the diagnosis]. Which I understood cos I said, you know, ‘if you want to back out now, 
now’s your chance to if you don’t think you can handle it.’…Basically he doesn’t want to see 
me deteriorate and stuff like that…he said it would be too hard for him.”   
                                                                                                Participant 6, female with DM1                                                                                     
 
One participant described a strained relationship with her partner as a result of 
miscommunication, leading to a misunderstanding about her diagnosis. 
 “The only person was my husband. And, uhm, I told him really early, really early on in our 
relationship but he says I didn’t….He doesn’t remember but anyway, I kept saying to him 
‘You know my Dad, I’m going to be like Dad.’ But he couldn’t believe it. He [would say] ‘But 
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you’re not like your Dad.’ He couldn’t believe it cos I was normal and he couldn’t see it, 
uhm, but of course it’s happened. He can see it now.”         
                                                                                                   Participant 1, female with DM1                 
 
Some participants, who did not have partners, were concerned about driving a partner away 
in the future by disclosing their diagnosis of DM1.  
“Like, in the future, like, when I get married or whatever it would be something that my wife 
would have to, it would be something that I would have to explain to my wife about…I’d have 
to explain it and if I explained it wrong you know it could potentially drive them away.”  
                                                                                                 Participant 10, male with DM1                                                                                                                                                                                                                                                                        
 
Furthermore, participants described the need to tell a future partner about their diagnosis, as 
they recognised partners would likely become their future carers. One man described the 
complexities of these discussions due to the additional pressures a diagnosis of DM1 places 
on intimate partner relationships. 
“If I was thinking about getting married, I would have to tell the person that I was thinking 
about getting married with, before they said yes. You know, ‘this is what you are going to be 
in for. You know, in ten years, you are probably going to spend the last five years of my life 
caring for me. And I may not be in the position to care for you.’”          
                                                                                                Participant 16, male with DM1       
Minimising Narratives 
The majority of participants described narratives whereby individuals compared their own 
diagnosis to other ‘problems’ which they perceived to be worse. These narratives minimised 
the potential severity of myotonic dystrophy. 
“There’s worse things than what I’ve got, you know. People have got worse conditions. Polio 
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and they can never walk properly for the whole of their lives. Parkinson’s is not very nice I 
mean, you know, there’s all sorts of things. I could be worse off, you know.”          
                                                                                                Participant 1, female with DM1  
A number of participants compared their diagnosis to Duchenne Muscular Dystrophy 
specifically, which they perceived to be ‘worse’.  
 “There’s a lot of muscular dystrophies out there that are worse than mine. Like the kids who 
have got Duchenne’s, they don’t live very long.”   
                                                                                              Participant 13, female with DM1                 
Interwoven with these minimizing narratives was the idea that families needed to ‘get on with 
life’ following a diagnosis of myotonic dystrophy. 
“When my nephew was alive...he just kept talking about it and talking about it and talking 
about it. It used to annoy me because I mean if you’ve got it you’ve got it and you just need to 
get on with life and do what you can, you know. But, uhm, we don’t talk about it.”  
                                                                                               Participant 17, female with DM1  
Discussion 
This study sought to explore the experiences of communication in New Zealand (NZ) 
families following a diagnosis of myotonic dystrophy (DM1), to gain insight into the factors 
influencing communication about genetic risk information. This is the first study exploring 
the experiences of family communication about DM1, and also the first to explore family 
communication within a New Zealand population. The results identified that NZ families’ 
approach to communication about DM1 varies, depending on their unique experience of 
DM1. While most participants reported that either they or a female relative told immediate 
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family members about their diagnosis, they assumed this information had then been 
communicated to the wider family. In keeping with the wider literature, this research 
reinforced the pivotal role of women as ‘messengers’ of genetic information within families. 
When considering motivations to disclose information about a diagnosis of DM1, participants 
consistently described the importance of promoting medical and reproductive autonomy of 
family members. Importantly, communication decisions had both positive and negative 
impacts on family and intimate partner relationships.  
Participant narratives revealed the diverse approaches of communicating about DM1 both 
within and among New Zealand families. Some families valued openness, and others avoided 
discussion about DM1. This observation is consistent with other studies exploring family 
communication about genetic or health issues (Mellon et al., 2006; Dancyger et al., 2011). It 
is logical that diversity exists in the way families approach communication, as families 
themselves are unique and will experience change in different ways. DM1 is a variable 
condition even within the same family, and therefore family members may experience DM1 
in vastly different ways too. As well as the unique experience of DM1 , pre-existing family 
dynamics and cohesiveness, gender and communication values contributed to the diverse 
narratives about myotonic dystrophy within and among New Zealand families. 
In this cohort, participants described clearly defined expectations about how they should talk 
about myotonic dystrophy within the family. Beliefs and understandings about ‘appropriate 
communication’ evolve within family units and act to maintain communication through 
coordination of “oughts” and “shoulds” (Bylund, Galvin & Gaff, 2010, p.9). One woman 
commented ‘everyone talks about it’ and therefore recognised that openness was a shared 
communication value in her family. In comparison a male participant described that his 
diagnosis of DM1 was ‘like an unspoken thing,’ suggesting that relatives were aware of his 
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diagnosis although there was an expectation that this was not to be discussed in an ongoing 
manner. It was not explicitly stated that authoritative family figures determined 
communication behaviours, as has been suggested by other studies (Forrest et al., 2003; 
Plumridge et al., 2010). Rather, participants in this study ‘learnt’ communication expectations 
through their own experiences of discomfort after going against the grain, or through 
observing the communication behaviours of other family members. 
Consistent with the literature, most participants described that immediate family members 
were actively told about DM1, while it was often assumed that extended relatives had been 
informed by independent family members. A number of studies have reported that 
individuals are more likely to disclose genetic risk information to first degree relatives, and to 
relatives with whom individuals feel stronger emotional bonds (Claes et al., 2003; Peterson et 
al., 2003; Coates et al., 2007). Although participants described the task of informing relatives 
about DM1 as being emotionally burdensome, they recognised the importance of 
communication. Demonstrating this point further, a number of women reported actively 
stepping past a gate-keeper in the family, to ensure relatives in the next generation were told 
as they approached reproductive age.  
Women were central to family communication about DM1, even when DM1 was on their 
partner’s side of the family. This was in contrast to male participants, who did not identify 
themselves as ‘messengers’. The role of women in communicating and managing family 
health information is a phenomenon that has been well recognised (d’Agincourt-Canning, 
2001; Foster et al., 2004).  While both males and females in this study were aware of the 
implications of their diagnosis for family members, males reported experiencing greater 
discomfort in talking about this with their family members and described a reliance on female 
relatives. In this cohort, females were primarily responsible for informing at-risk relatives. It 
 22 
seemed that this ‘gendered’ approach to communication was implicit and deemed to be 
appropriate within families.  
The concept of women being more likely to communicate genetic test results with their 
relatives, compared to men, has been observed in other studies (d’Agincourt- Canning, 2001; 
Forrest et al., 2003; Gaff et al., 2005; Finlay et al., 2008; Bruwer et al., 2013). It has been 
proposed that societal gender constructs impose stronger moral obligations on women to take 
on the ‘messenger’ role, through expectations of being ‘carers’ (d’Agincourt-Canning 2001; 
Foster et al., 2004). This gendered obligation was not explicitly stated by participants in this 
study; rather, most participants described intrinsic understandings that females facilitated 
communication about DM1 within families. Gender expectations may intersect with 
communication in the opposite sense, encouraging males to adopt the belief of ‘strength in 
silence’ (Foster et al., 2004, p. 452). It follows that although women described emotional 
difficulties accompanied with disclosing genetic information, these conversations seemed 
more natural to women. This concept is in keeping with the conclusions of another study 
exploring family communication about Lynch Syndrome, which identified that women felt it 
was ‘normal’ to communicate about genetic issues, while men did not (Gaff et al., 2005).  
Engagement with genetic health services appeared to be another gendered activity in this 
cohort. This is consistent with observations in the broader healthcare setting, where women 
are more likely to engage with healthcare services than men (Stefan, 2015; Wellstead, 2011). 
Male participants were commonly encouraged to have genetic testing by another female 
relative and seemed to be more easily deterred from engaging with genetic health services. 
For example one male participant described that his sister told him about the condition in his 
family but he did not have the ‘correct name’, which prevented him from seeking genetic 
testing. This may provide insight as to why uptake of genetic testing is generally lower in 
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men (McAllister et al., 1998; Finlay et al., 2008). Women in this study, on the other hand, 
were more likely to advocate for themselves and their families, taking control of the 
communication process to ensure ‘at-risk’ relatives were informed.  
Autonomy was consistently described by participants when considering whether to disclose 
information about their diagnosis of DM1 to family members. Participants recognised the 
importance of equipping relatives with information about their diagnosis of DM1, 
particularly in the context of reproductive decision making and medical management. While 
this was described by most participants, males generally did not act on this motivator 
themselves; rather, a female ‘messenger’ did.  
Women in this study commonly associated communication decisions with potential 
pregnancy outcomes of other relatives. This concept went a step further for some women, 
who described feeling a sense of responsibility for the potential outcomes of other relatives’ 
communication decisions, encouraging a number of women to step past a ‘gate-keeper.’ For 
example, participant 4 described feeling a responsibility to inform her female cousins so they 
could make informed reproductive decisions. The literature commenting on gender roles and 
responsibilities in relation to pregnancy (Rapp, 2000; Ettore, 2000), describes the societal 
notion that women are responsible for maintaining the health of a pregnancy and in turn ‘take 
responsibility if things go wrong’ (Reed, 2007, p. 344). Women receive strong social and 
medically driven messages encouraging information seeking and adoption of healthy 
behaviours prior to and throughout a pregnancy, instilling the concept of maternal 
responsibility (Rapp, 2000). Although DM1 affects men and women equally in a medical 
sense, women are faced with greater reproductive risks associated with pregnancy. One could 
therefore propose that the reproductive risks associated with being a female with DM1 or 
having a child with DM1 instill a stronger sense of responsibility towards disclosure in 
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women compared to men. The findings of this study build on the concept of gendering of 
responsibility in pregnancy, suggesting that maternal responsibility has a role in 
communication about genetic risk information.  
Although non-disclosure was not a commonly reported outcome, the implications of non-
disclosure were significant in this cohort: it severed relationships and frustrated reproductive 
choice. Both participants who were on the receiving end of non-disclosure felt ‘control was 
taken away’ when making reproductive decisions, and both stated they wouldn’t have chosen 
to conceive ‘naturally’ had they known about DM1. Furthermore, both women went on to 
have another child after learning about DM1, either through Pre-implantation Genetic 
Diagnosis (PGD) or adoption. These narratives were powerful, leading one to consider the 
impact of non-disclosure on parent-child relationships when reproductive autonomy has been 
impeded. The realisation of frustration of reproductive choice is exposed in the narrative 
between a mother (2) and daughter (1), where participant 1asks ‘You could have avoided 
having me?’ to which her mother responds ‘Yeh, well, yeh.’ This brief exchange reveals a 
now spoken knowledge that this woman is here because her parents did not know there was a 
choice. Very little is known about the long term impact of non-disclosure on these 
relationships, however these narratives demonstrate the ethical tension that exists between 
individual autonomy and the rights of the wider family to be informed about genetic risk 
information. Frustration of reproductive autonomy has been described as a result of non-
disclosure in the literature, and some individuals have legally challenged that non-disclosure 
and the potential role of health professionals involved is a form of ‘actionable negligence’ 
and a violation of Human Rights (Chico, 2016). 
Decisions to tell or withhold information about DM1 altered family relationships and 
dynamics significantly for some participants in this study. Some participants described that 
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disclosure had strengthened relationships with family members. The genetic counselling 
literature suggests that disclosure can provide avenues for social and emotional support, 
which can have the effect of strengthening relationships (d’Agincourt-Canning, 2001; Wilson 
et al., 2004). However, some participants described that disclosure about DM1 had weakened 
family relationships. One participant described how his brother no longer visits or contacts 
him as he ‘does not want to be reminded.’ It seems that disclosure can create tension and a 
sense of disconnection within family units, particularly between family members who have 
opposing coping styles (Speice, McDaniel, Rowley & Loader, 2002). 
Although this study did not specifically aim to explore communication about DM1 with a 
spouse, a number of participants raised this as being a challenging task, carrying significant 
impact. Several authors have acknowledged the importance of openness and self-disclosure 
in the development of healthy intimate relationships (Dindia, 2002; Troy & Lewis-Smith, 
2006; Hoskins et al., 2008). Although most participants reported that they had or theoretically 
would disclose their diagnosis to a partner, individuals commented on the complexities of 
this communication and recognised that this could be life changing, fearing the potential 
impact on relationships. Some participants reported that the decision to tell their partner 
about their diagnosis of DM1 resulted in the breakdown of a relationship.  Others described 
how tension had evolved within their relationship from a misunderstanding arising from 
communication about DM1. Furthermore, a number of participants who did not have a 
partner stated that they anticipated telling a partner about their diagnosis would be a difficult 
task, with one man fearing this would ‘drive them away’. Participants acknowledged that 
DM1 placed unique pressures on intimate relationships. For example, one participant 
attributed the breakdown of her relationship to the degenerative nature of DM1, with her 
partner saying that he would find it emotionally too difficult to witness her ‘deteriorate’. 
Similarly, others mentioned that the reality of their partner needing to become their carer in 
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the future placed practical pressures on their relationship. 
Minimising narratives about DM1 seemed to evolve within families as a way to cope with the 
challenges posed by this condition. The majority of participants described narratives which 
minimised the effect of DM1 and encouraged families to ‘get on with life.’ Narrative 
formation can have an important role in families learning to adapt to life after a diagnosis 
(Biesecker & Erby, 2008; Trees et al., 2010). Interestingly, narratives of ‘it could be worse’ 
demonstrated a mechanism of adaption for participants in this study, as they compared their 
situation to individuals with other conditions which they perceived to be worse, reminding 
themselves that they were ‘lucky’. It seems that participants and their families learnt to cope 
and adapt to DM1 by ‘shifting comparison standards’ (Biesecker & Erby, 2008). However, 
these narratives seemed to neglect an acknowledgement that DM1 could indeed be severe. 
One could not help but recognise that the impact of DM1 on participants seemed to be far 
more significant than what these narratives encapsulated. For example, the majority of 
participants in this study had experienced significant loss as a result of DM1, whether this be 
the loss of their health; the loss of a parent, child, extended relative, pregnancy; or the loss of 
choice. Furthermore, narratives about needing to ‘get on with life’ seemed to encourage 
individuals to move on from these losses, rather than ‘dwell’ on them by talking. One could 
therefore argue that minimising narratives might have the effect of restricting ongoing 
communication about DM1 within families. 
Practice Implications 
Based on the findings of this study, it is clear that reproductive decision making is a driving 
factor for communication about DM1 within families. When individuals know about DM1 in 
the family, they can access genetic testing to clarify their gene status, allowing individuals to 
make informed choices about family planning and reproductive options. Genetic counsellors 
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have a crucial role in providing patient and family centered information and psychosocial 
support, to facilitate family communication and therefore to promote informed medical and 
reproductive decision making in the wider family. The findings of this small, exploratory 
study suggest that there may be value in longitudinal genetic counselling support, appropriate 
to an individual’s life stage. Individuals may require additional genetic counselling support as 
they, or other family members, approach reproductive age.  
 
Furthermore, these findings reveal the challenges that can emerge from communicating about 
a diagnosis of DM1 with a spouse. Pre-test genetic counselling should explore spousal 
relationships and encourage patients to consider the possibility of changes in established 
relationships. Spouses may benefit from attending pre-test genetic counselling sessions, to 
anticipate some of the ways DM1 may impact intimate partner relationships and to explore 
future decision making. Counselling should also encourage un-partnered individuals to 
consider having to tell a new partner in the future. Genetic counsellors should be aware 
unaffected spouses can be central to family communication processes, and therefore it is 
important spouses have access to individual and family centred information about DM1, and 
are offered practical and psychosocial support from genetic counsellors.   
 
Lastly, these findings demonstrate that males who access genetic health services would likely 
benefit from ongoing genetic counselling support to facilitate dissemination of genetic risk 
information. Additional efforts may be required to engage males with genetic health services 
and this should be considered when meeting with male patients and with individuals who 
have male relatives.  
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Gene carrier review programs should be considered as a model of care to provide the ongoing 
genetic counselling support to actively work with families regarding family communication 
and medical management. Clinical gene carrier review programs could provide a framework 
to ensure individuals are able to access life stage specific genetic counselling support, 
particularly prior to family planning and pregnancy.   
 
Study Limitations 
This study design involved interviewing an individual or select family members, thereby 
neglecting the wider family perspective. Narratives about family communication and DM1 
may be different or conflicting between family members. It would therefore have been 
helpful to explore the perspectives of multiple members of the same family in interviews. 
This being said, the literature acknowledges that “family members’ behaviours serve as 
indicators of the overall family themes” (Bylund et al., 2010, p.9) and therefore an 
individual’s narrative is likely to capture a broader family narrative.  
 
Although qualitative methodologies allow the collection of rich, experiential data, the nature 
of this research means that the findings are not generalizable. Nevertheless, they provide 
health professionals and researchers with an in-depth insight into the experiences of a select 
number of New Zealanders and their families communicating about DM1. 
 
Myotonic dystrophy is a variable condition, which can be associated with variable levels of 
cognitive impairment in some individuals. The inclusion criteria for the present study meant 
individuals had to have capacity to provide consent in order to be eligible. One could propose 
that cognitive impairment could introduce barriers to family communication, however this 




A number of participants in this study raised the issue of disclosure of genetic risk 
information with a partner, without being prompted by the interview guide. Due to the 
degenerative nature of DM1 and the possible reproductive implications, individuals are faced 
with a unique set of challenges when disclosing their diagnosis to a partner. Further research 
is needed to address how individuals navigate these challenges and whether gender roles 
intersect with this process.  
 
One could speculate that the presence of minimising narratives within family units may 
reduce individuals’ perception of their genetic risk, however this remains unclear. Further 
research is required to better understand the impact of families employing minimising 
narratives to communicate about genetic risk information, specifically considering risk 
perception of relatives.  
 
Conclusion 
This study explored family communication in a group of New Zealand individuals who have 
a clinical/molecular diagnosis of DM1, using in-depth interviews. The findings demonstrate 
the diversity among and within families, with several different family narratives about DM1 
described. The majority of participants described a motivation to tell relatives about DM1, to 
promote autonomy by facilitating targeted healthcare and reproductive choice. The findings 
support the central role many women play as holders and communicators of family health 
information, and build on the concept of gendering of responsibility, suggesting that maternal 
responsibility and a desire to promote relatives’ reproductive autonomy motivates women to 
take on the messenger role in families. Participants described how the presence of DM1 in 
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the family, and in themselves, altered family relationships. Most families adopted narratives 
that minimised the impact of DM1, demonstrating how family narratives and ongoing 
communication present coping strategies to adapt to and process the challenges imposed by 
DM1. Genetic counselling should be offered to all individuals receiving a diagnosis of DM1 
and to those considering predictive testing. DM1 presents unique challenges within families 
following a diagnosis and throughout the process of communication. Individuals require time 
and life stage appropriate support to explore these unique challenges to maximise individual 
and family well-being and autonomy. The findings of this small, exploratory study suggest 
that there may be value in longitudinal genetic counselling, perhaps as part of a multi-
disciplinary management clinic.  
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